Cite
HARVARD Citation
Chou, W. et al. (2017). Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher‐risk myelodysplastic syndromes. Asia-Pacific journal of clinical oncology. 13 (5), pp. e430-e439. [Online].